Literature DB >> 11585998

Acute profound thrombocytopenia associated with anaphylactic reaction after abciximab therapy during percutaneous coronary angioplasty.

Y Iakovou, A Manginas, E Melissari, D V Cokkinos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11585998     DOI： 10.1159/000047375

Source DB:  PubMed          Journal:  Cardiology        ISSN： 0008-6312            Impact factor:   1.869


× No keyword cloud information.
  5 in total

Review 1.  Glycoprotein IIb/IIIa inhibitor-induced thrombocytopenia: diagnosis and treatment.

Authors:  S M Said; J Hahn; E Schleyer; M Müller; G M Fiedler; M Buerke; R Prondzinsky
Journal:  Clin Res Cardiol       Date:  2006-12-08       Impact factor: 5.460

2.  Acute profound abciximab induced thrombocytopenia: a correct management of a methodological error.

Authors:  Gaetano Tanzilli; Martina Sordi; Alessio Arrivi; Enrico Mangieri; Massimiliano Scappaticci
Journal:  BMJ Case Rep       Date:  2009-10-05

3.  Allergic reaction to abciximab with atypical manifestations.

Authors:  Abdulrahman M Al-Moghairi; Moheeb A Abdullah
Journal:  J Saudi Heart Assoc       Date:  2011-01-06

Review 4.  Hypersensitivity reactions to modern antiplatelet and anticoagulant drugs.

Authors:  Kathrin Scherer Hofmeier
Journal:  Allergo J Int       Date:  2015-03-14

5. 

Authors:  Askin Gülsen; Bettina Wedi; Uta Jappe
Journal:  Allergo J       Date:  2020-06-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.